Our experienced team delivers scientific excellence while reducing your development timeline and risk.
Accelerate Your Drug Discovery with Expert Medicinal Chemistry at GD3
Providing Custom Solutions for Your Complex Chemistry Challenges
At GD3, we specialize in transforming early chemical hits into viable clinical candidates. Our team of expert scientists applies their decades of experience in drug discovery to use an integrated optimization approach by combining structure-based data, ADME profiling, and innovative design strategies to deliver drug candidates that are potent, selective, safe, and effective.
We partner closely with clients, tailoring solutions to quickly transform your hits into clinical candidates while protecting your intellectual property.
Why Leading Biopharma Teams Choose GD3
- Faster Time to Market: Our integrated approach and experienced team accelerate your compounds from hit identification to clinical candidates
- Reduced Risk: Comprehensive structure-activity relationship analysis combined with in vitro ADME profiling minimize late-stage failures
- Complete IP Protection: You retain 100% ownership of all intellectual property while we help build robust patent strategies
- Experienced Team: Scientists with proven success across diverse therapeutic areas
- Collaborative Approach: Seamless communication and project alignment with your goals
- Proven Results: Successfully advanced compounds across diverse therapeutic areas with our collaborative, results-driven approach
GD3 Provides Custom Solutions for the Most Complex Chemistry Challenges.
Hit-to-Lead Services
The first step toward a successful drug candidate is identifying and refining promising small-molecule hits. We will turn your initial screening results into viable lead compounds through our systematic optimization process which will help you quickly assess, prioritize, and evolve hits into optimized lead series.
Our Hit-to-Lead Services Include:
- Hit confirmation through re-synthesis and purification
- Hit analysis (initial SAR) and risk assessment (structural liabilities, PAINS analysis)
- Hit expansion via design and synthesis of analogs for scaffold evaluation, as well as SAR exploration
- Preliminary ADME assessment
- Selection of 2–3 lead series based on SAR and ADME
Transform screening hits into promising drug-like lead compounds in 3-6 months.
Lead Optimization
Once lead compounds are identified, our integrated platform enables rapid optimization to advance them into pharmacokinetic and in vivo efficacy studies. We design and synthesize analogs, optimizing for potency, selectivity, pharmacokinetics, and IP strength.
Our Lead Optimization Services Include:
- Comprehensive Design: strategically designed analogs targeting your specific profile requirements
- Multi-Parameter Optimization: Simultaneous improvement of potency, selectivity, ADME properties, and safety
- Patent Strategy Integration: Novelty and patentability considerations built into every design cycle
- Pharmacokinetic Advancement: Direct progression to PK studies and in vivo efficacy testing
Advance your leads to clinical candidates
in 1-2 years
Structure-Based Drug Design (SBDD)
Whenever possible, we leverage structural biology to accelerate optimization and dramatically improve your compound design efficiency. By using X-ray crystallography data, molecular modeling, and biophysical analysis, we transform weak leads into highly potent and selective candidates with higher probability of clinical success.
Transforming Structural Insights into Clinical Success
Intellectual Property Protection
We recognize that IP is a core value driver in drug discovery. At GD3, all intellectual property generated in your project belongs 100% to you. We collaborate with your team and patent attorneys to develop strong, defensible claims while ensuring complete confidentiality.
We Provide:
- 100% Client Ownership: All intellectual property generated belongs entirely to you
- Strategic Patent Planning: Collaborative development of comprehensive IP strategies with broad coverage
- Complete Confidentiality: Strict NDAs and secure data management protect your competitive advantage
- Freedom to Operate: Thorough IP landscape analysis ensures clear development pathways
Your Innovation, Fully Protected
